Phase 3 Success for Mezigdomide Signals New Path for Next-Generation CELMoD Therapies in Multiple Myeloma (https://www.myeloma.org/news-events/multiple-myeloma-news/phase-3-trial-success-for-mezigdomide-in-myeloma)